Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 20Recruiting 10Terminated 4Active not recruiting 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 20Genitourinary 2Sarcoma 1Head & Neck 1

Conditions

Sarcoma 60Gliosarcoma 19Glioblastoma 19Osteosarcoma 15Lymphoma 14Central Nervous System Neoplasms 13Dendritic Cell Sarcoma, Interdigitating 11Rhabdomyosarcoma 10Oligodendroglioma 10Neuroblastoma 10Neoplasms 10Lymphoma, Large B-Cell, Diffuse 10Brain Neoplasms 10Bone Neoplasms 10Astrocytoma 10Recurrence 9Breast Neoplasms 9Sarcoma, Ewing 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma, Non-Hodgkin 8Liposarcoma 8Glioma 8Burkitt Lymphoma 8Wilms Tumor 7Neoplasm Metastasis 7Melanoma 7Hodgkin Disease 7Gastrointestinal Stromal Tumors 7Ovarian Neoplasms 6Medulloblastoma 6

Interventions

Melphalan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Skin Neoplasms × Sarcoma × Clear all
NCT02507076 2015-07-23

Isolated Limb Perfusion With Melphalan in Treating Patients With Stage IIIB-IV Melanoma or Sarcoma

Albert Einstein College of Medicine

Phase NA Withdrawn
DermatologicSarcoma

Carcinoma, Basal Cell, Melanoma, Sarcoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡